Unauthorized Access Vulnerability in Oracle Life Sciences Central Designer
CVE-2026-21974

5.3MEDIUM

Key Information:

Vendor

Oracle
Status
Oracle Life Sciences Central Designer
Vendor
CVE Published:
20 January 2026

What is CVE-2026-21974?

A vulnerability in Oracle Life Sciences Central Designer allows unauthenticated attackers with network access via HTTP to access sensitive data. The affected version, 7.0.1.0, is prone to exploitation, resulting in unauthorized read access to certain data within the platform. This issue highlights the importance of securing applications against network-based threats.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Oracle Life Sciences Central Designer 7.0.1.0

References

https://www.oracle.com/security-alerts/cpujan2026.html
vendor-advisory

CVSS V3.1

Score:
5.3
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
None
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.